Plain-English translation of NCT07031336 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing a new type of CT scanner called a photon-counting CT scanner to see if it can take better, clearer pictures of your lungs and measure emphysema and airway damage more accurately. This study compares the new scanner to the standard CT scanner you may have already had. The goal is to figure out the best settings to use with the new scanner so doctors can reliably track lung disease over time.
Current CT scanners work well, but this new technology might produce clearer images and more accurate measurements of lung damage, which could help doctors better understand and monitor COPD in their patients.
You likely qualify if…
You likely don't qualify if…
You will have one additional chest CT scan using the new photon-counting scanner during your regular COPDGene Phase 4 visit. This scan takes just a few minutes and uses a radiation dose similar to about six months of natural background radiation. Your images will then be processed using different computer settings to find the best way to measure lung damage accurately.
AI-generated summary from trial data · Aug 28, 2026 · Not medical advice
United States
Sponsor
Duke University
Enrollment target
~40 participants
Started
November 2025
Primary completion
December 2026
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Wendy Curry
Duke University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.